110 related articles for article (PubMed ID: 7911667)
21. Physiological action tremor: a basis for understanding alcohol withdrawal tremor.
Burgstahler SA; Wittmers LE; Petry RW; Pozos RS
Curr Alcohol; 1981; 8():79-84. PubMed ID: 7343196
[TBL] [Abstract][Full Text] [Related]
22. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
Kotlinska J; Pachuta A; Bochenski M; Silberring J
Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
[TBL] [Abstract][Full Text] [Related]
23. Neurocircuitry targets in ethanol reward and dependence.
Koob GF; Roberts AJ; Schulteis G; Parsons LH; Heyser CJ; Hyytiä P; Merlo-Pich E; Weiss F
Alcohol Clin Exp Res; 1998 Feb; 22(1):3-9. PubMed ID: 9514280
[TBL] [Abstract][Full Text] [Related]
24. Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal.
Glue P; Nutt D
Br J Psychiatry; 1990 Oct; 157():491-9. PubMed ID: 1983388
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of harmaline-induced tremor activity in mice.
Paterson NE; Malekiani SA; Foreman MM; Olivier B; Hanania T
Eur J Pharmacol; 2009 Aug; 616(1-3):73-80. PubMed ID: 19497322
[TBL] [Abstract][Full Text] [Related]
26. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis.
Rasmussen DD; Boldt BM; Bryant CA; Mitton DR; Larsen SA; Wilkinson CW
Alcohol Clin Exp Res; 2000 Dec; 24(12):1836-49. PubMed ID: 11141043
[TBL] [Abstract][Full Text] [Related]
27. Serotonergic anti-depressants and ethanol withdrawal syndrome: a review.
Uzbay IT
Alcohol Alcohol; 2008; 43(1):15-24. PubMed ID: 17934195
[TBL] [Abstract][Full Text] [Related]
28. MK-801 can exacerbate or attenuate behavioral alterations associated with neonatal alcohol exposure in the rat, depending on the timing of administration.
Thomas JD; Fleming And SL; Riley EP
Alcohol Clin Exp Res; 2001 May; 25(5):764-73. PubMed ID: 11371726
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes.
Dhir A; Naidu PS; Kulkarni SK
Addict Biol; 2005 Dec; 10(4):329-35. PubMed ID: 16318954
[TBL] [Abstract][Full Text] [Related]
30. Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal.
Lal H; Prather PL; Rezazadeh SM
Alcohol Clin Exp Res; 1993 Apr; 17(2):411-7. PubMed ID: 8488986
[TBL] [Abstract][Full Text] [Related]
31. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
Baghdadli A; Gonnier V; Aussilloux C
Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
[TBL] [Abstract][Full Text] [Related]
32. [Treatment alternatives of alcohol withdrawal delirium].
Tiecks FP; Einhäupl KM
Nervenarzt; 1994 Apr; 65(4):213-9. PubMed ID: 8015628
[TBL] [Abstract][Full Text] [Related]
33. Effect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in rats.
Gupta GL; Rana AC
Indian J Exp Biol; 2008 Jun; 46(6):470-5. PubMed ID: 18697607
[TBL] [Abstract][Full Text] [Related]
34. Administration of low doses of MK-801 during ethanol withdrawal in the developing rat pup attenuates alcohol's teratogenic effects.
Thomas JD; Fleming SL; Riley EP
Alcohol Clin Exp Res; 2002 Aug; 26(8):1307-13. PubMed ID: 12198409
[TBL] [Abstract][Full Text] [Related]
35. Fear state induced by ethanol withdrawal may be due to the sensitization of the neural substrates of aversion in the dPAG.
Cabral A; Isoardi N; Salum C; Macedo CE; Nobre MJ; Molina VA; Brandão ML
Exp Neurol; 2006 Jul; 200(1):200-8. PubMed ID: 16624300
[TBL] [Abstract][Full Text] [Related]
36. Prenatal exposure of Long-Evans rats to 17alpha-ethinylestradiol modifies neither latent inhibition nor prepulse inhibition of the startle reflex but elicits minor deficits in exploratory behavior.
Sandner G; Silva RC; Angst MJ; Knobloch J; Danion JM
Brain Res Dev Brain Res; 2004 Sep; 152(2):177-87. PubMed ID: 15351506
[TBL] [Abstract][Full Text] [Related]
37. A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders.
Castaneda R; Sussman N; Westreich L; Levy R; O'Malley M
J Clin Psychiatry; 1996 May; 57(5):207-12. PubMed ID: 8626352
[TBL] [Abstract][Full Text] [Related]
38. The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety.
Gallate JE; Morley KC; Ambermoon P; McGregor IS
Psychopharmacology (Berl); 2003 Feb; 166(1):51-60. PubMed ID: 12474111
[TBL] [Abstract][Full Text] [Related]
39. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Haleem DJ; Samad N; Haleem MA
Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
[TBL] [Abstract][Full Text] [Related]
40. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
